Evidence map›Paper›PMID 32246572›Full record

ReviewInternational journal of urology : official journal of the Japanese Urological Association2020

Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Yoshiyuki Akiyama, Yi Luo, Philip M Hanno, Daichi Maeda, Yukio Homma

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in International journal of urology : official journal of the Japanese Urological Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04789135 (Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis/Bladder Pain Syndrome), which is not on this map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04789135 phase2unknown statusnot on this map

Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis/Bladder Pain Syndrome

TypeinterventionalSponsorAnhembi Morumbi UniversityRan2020 to 2021Enrolled50ConditionsInterstitial Cystitis, Chronic, Bladder Pain SyndromeArmsOzone
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 167 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Animal Models of Hunner-Type Interstitial Cystitis.International journal of urology : official journal of the Japanese Urological Association · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Yoshiyuki AkiyamaDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yi LuoDepartment of Urology, University of Iowa, Iowa City, Iowa, USA.
Philip M HannoDepartment of Urology, Stanford University School of Medicine, Stanford, California, USA.
Daichi MaedaDepartment of Clinical Genomics, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yukio HommaJapanese Red Cross Medical Center, Tokyo, Japan.
University of Iowa · USJapanese Red Cross Medical Center · JPOsaka University · JPStanford University · US

Funding

Inhibition of TLR4 for Treatment of Cystitis PainR01DK111396 · NIDDK · UNIVERSITY OF IOWA · PI LUO, YI · 2017 to 2020
$1.4M
Japanese Society for the Promotion of Science 19K07433Japanese Society for the Promotion of Science 19K18552Japan Intractable Diseases Research FoundationMinistry of Health, Labor and Welfare 18060798NIDDK NIH HHS R01 DK111396NIDDK NIH HHS R01-DK-111396
6 · The paper itself

Abstract

Interstitial cystitis/bladder pain syndrome is a debilitating condition of unknown etiology characterized by persistent pelvic pain with lower urinary tract symptoms and comprises a wide variety of potentially clinically useful phenotypes with different possible etiologies. Current clinicopathological and genomic evidence suggests that interstitial cystitis/bladder pain syndrome should be categorized by the presence or absence of Hunner lesions, rather than by clinical phenotyping based on symptomatology. The Hunner lesion subtype is a distinct inflammatory disease with proven bladder etiology characterized by epithelial denudation and enhanced immune responses frequently accompanied by clonal expansion of infiltrating B cells, with potential engagement of infection. Meanwhile, the non-Hunner lesion subtype is a non-inflammatory disorder with little evidence of bladder etiology. It is potentially associated with urothelial malfunction and neurophysiological dysfunction, and frequently presents with somatic and/or psychological symptoms, that commonly result in central nervous sensitization. Animal models of autoimmune cystitis and neurogenic sensitization might serve as disease models for the Hunner lesion and non-Hunner lesion subtypes, respectively. Here, we revisit the taxonomy of interstitial cystitis/bladder pain syndrome according to current research, and discuss its potential pathophysiology and representative animal models. Categorization of interstitial cystitis/bladder pain syndrome based on cystoscopy is mandatory to design optimized treatment and research strategies for each subtype. A tailored approach that specifically targets the characteristic inflammation and epithelial denudation for the Hunner lesion subtype, or the urothelial malfunction, sensitized/altered nervous system and psychosocial problems for the non-Hunner lesion subtype, is essential for better clinical management and research progress in this complex condition.

Indexed as

Cystitis, InterstitialAnimalsCystoscopyModels, AnimalPelvic Painanimal modelautoimmune cystitisbladder pain syndromeinterstitial cystitispathophysiology

Identifiers

PMID32246572
PMCPMC7768977
OpenAlexW3014604613

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.